Do <i>MDM2</i> SNP309 and <i>TP53</i> R72P Interact in Breast Cancer Susceptibility? A Large Pooled Series from the Breast Cancer Association ConsortiumMarjanka K. Schmidt, Laura J. van’t Veer, Julian Peto et al.|Cancer Research|2007Cited by 79
Specific genomic aberrations in primary colorectal cancer are associated with liver metastasesSjoerd C. Bruin, Laura J. van’t Veer, Christiaan Klijn et al.|BMC Cancer|2010Cited by 40
Breast Cancer Risk and 6q22.33: Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2Tomas Kirchhoff, Fleur Hammet, Mia M. Gaudet et al.|PLoS ONE|2012Cited by 13
SNP rs2180341 per-allele hazard ratios (HRs) and 95% confidence intervals (CIs) among Consortium of Investigators of Modifiers of <i>BRCA1/2</i> (CIMBA) in A. <i>BRCA1</i> mutation carriers B. <i>BRCA2</i> mutation carriers.Tomas Kirchhoff, Thijs Van Dorpe, Mia M. Gaudet et al.|Figshare|2015Cited by 0